Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hilgard

Showing results (81-90 of 135) with videos related to

Pageof 14
Sort By:
Biochimica Et Biophysica Acta|April 9, 1990
Biotransformation of mafosfamide in P388 mice leukemia cells: intracellular 31P-NMR studiesH M Sonawat, D Leibfritz, J Engel, et al.
Progress in Experimental Tumor Research|January 1, 1992
Experimental therapeutic studies with miltefosine in rats and miceP Hilgard, J Stekar, R Voegeli, et al.
Investigational New Drugs|January 1, 1984
Experimental toxicology of ASTA Z 7557 (INN mafosfamide)J Pohl, P Hilgard, W Jahn, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Current development of podophyllotoxinsR Canetta, P Hilgard, S Florentine, et al.
Zeitschrift Fur Rheumaforschung|January 1, 1971
[Influence of drug-induced plasminemia on the readiness for inflammation]H Nissen, H Feyen, H Rasche, et al.
Cancer Investigation|January 1, 1988
Basis and new developments in the field of oxazaphosphorinesN Brock, P Hilgard, M Peukert, et al.
Lancet (London, England)|June 25, 1983
Bioactivity of cyclophosphamide preparationsP Hilgard, J Engel, U Niemeyer, et al.
European Journal of Cancer|June 1, 1972
The effect of heparin on the initial phase of metastasis formationP Hilgard, L Beyerle, R Hohage, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1984
Pharmacokinetics and mechanism of action of detoxifying low-molecular-weight thiolsN Brock, P Hilgard, J Pohl, et al.
British Journal of Cancer|January 1, 1980
Mechanisms of C. Parvum-induced coagulopathy in miceH D Mitcheson, P Hilgard, A McCraw, et al.
Pageof 14

Showing results (81-90 of 135) with videos related to

Sort By:
Pageof 14
Biochimica Et Biophysica Acta|April 9, 1990
Biotransformation of mafosfamide in P388 mice leukemia cells: intracellular 31P-NMR studiesH M Sonawat, D Leibfritz, J Engel, et al.
Progress in Experimental Tumor Research|January 1, 1992
Experimental therapeutic studies with miltefosine in rats and miceP Hilgard, J Stekar, R Voegeli, et al.
Investigational New Drugs|January 1, 1984
Experimental toxicology of ASTA Z 7557 (INN mafosfamide)J Pohl, P Hilgard, W Jahn, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Current development of podophyllotoxinsR Canetta, P Hilgard, S Florentine, et al.
Zeitschrift Fur Rheumaforschung|January 1, 1971
[Influence of drug-induced plasminemia on the readiness for inflammation]H Nissen, H Feyen, H Rasche, et al.
Cancer Investigation|January 1, 1988
Basis and new developments in the field of oxazaphosphorinesN Brock, P Hilgard, M Peukert, et al.
Lancet (London, England)|June 25, 1983
Bioactivity of cyclophosphamide preparationsP Hilgard, J Engel, U Niemeyer, et al.
European Journal of Cancer|June 1, 1972
The effect of heparin on the initial phase of metastasis formationP Hilgard, L Beyerle, R Hohage, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1984
Pharmacokinetics and mechanism of action of detoxifying low-molecular-weight thiolsN Brock, P Hilgard, J Pohl, et al.
British Journal of Cancer|January 1, 1980
Mechanisms of C. Parvum-induced coagulopathy in miceH D Mitcheson, P Hilgard, A McCraw, et al.
Pageof 14